InvestWiser
ChemoMetec A/S
CHEMM · Nasdaq Copenhagen · Healthcare
550.50DKK
+6.1%last day
Price as of 2 October 2026
Performance
1 month
+6.6%
1 year
−11.6%
3 years, per year
+19.4%
5 years, per year
−11.7%
Largest fall, 3 years
−76.5%
Below the peak now
−49.0%
Volatility, 1 year
63.9%
Return with dividends reinvested.
Key figures
P/E
46.8
P/B
13.0
Dividend yield
1.3%
Return on equity
+27.8%
Net margin
+39.5%
Market value
1.4 bn USD
Quality, value and trend
Where ChemoMetec stands against every Nordic stock today. 100 is best.
100
Profitability and a sound balance sheet over time. Better than 100% of Nordic stocks.
8
The price measured against earnings, assets and cash flow. Better than 8% of Nordic stocks.
81
The price development over the past year. Better than 81% of Nordic stocks.
74
Quality, value and trend together. Better than 74% of Nordic stocks.
About ChemoMetec
ChemoMetec A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 170 employees.
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis